| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Colisto Nicholas | SVP & CIO | 8080 NORTON PARKWAY, MENTOR | /s/ Vikas Arora attorney-in-fact for Nicholas Colisto | 03 Mar 2026 | 0001565131 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | AVY | Common Stock | Options Exercise | $72,069 | +370 | +3.9% | $194.78 | 9,758 | 01 Mar 2026 | Direct | |
| transaction | AVY | Common Stock | Tax liability | $21,426 | -110 | -1.1% | $194.78 | 9,648 | 01 Mar 2026 | Direct | |
| transaction | AVY | Common Stock | Options Exercise | $67,783 | +348 | +3.6% | $194.78 | 9,996 | 01 Mar 2026 | Direct | |
| transaction | AVY | Common Stock | Tax liability | $17,530 | -90 | -0.9% | $194.78 | 9,906 | 01 Mar 2026 | Direct | |
| transaction | AVY | Common Stock | Options Exercise | $48,890 | +251 | +2.5% | $194.78 | 10,157 | 01 Mar 2026 | Direct | |
| transaction | AVY | Common Stock | Tax liability | $12,076 | -62 | -0.61% | $194.78 | 10,095 | 01 Mar 2026 | Direct | |
| transaction | AVY | Common Stock | Options Exercise | $83,950 | +431 | +4.3% | $194.78 | 10,526 | 01 Mar 2026 | Direct | |
| transaction | AVY | Common Stock | Tax liability | $20,452 | -105 | -1% | $194.78 | 10,421 | 01 Mar 2026 | Direct | |
| transaction | AVY | Common Stock | Options Exercise | $152,318 | +782 | +7.5% | $194.78 | 11,203 | 01 Mar 2026 | Direct | |
| transaction | AVY | Common Stock | Tax liability | $37,203 | -191 | -1.7% | $194.78 | 11,012 | 01 Mar 2026 | Direct |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | AVY | 2026 RSU Award | Award | $0 | +1,462 | $0.000000 | 1,462 | 01 Mar 2026 | Common Stock | 1,462 | $0.000000 | Direct | F1 | |
| transaction | AVY | 2026 PU Award | Award | $0 | +2,114 | $0.000000 | 2,114 | 01 Mar 2026 | Common Stock | 2,114 | $0.000000 | Direct | F2 | |
| transaction | AVY | 2022 MSU Award | Options Exercise | $0 | -370 | -100% | $0.000000 | 0 | 01 Mar 2026 | Common Stock | 370 | $0.000000 | Direct | F3 |
| transaction | AVY | 2023 MSU Award | Options Exercise | $0 | -348 | -50% | $0.000000 | 344 | 01 Mar 2026 | Common Stock | 348 | $0.000000 | Direct | F4 |
| transaction | AVY | 2024 MSU Award | Options Exercise | $0 | -251 | -32% | $0.000000 | 528 | 01 Mar 2026 | Common Stock | 251 | $0.000000 | Direct | F5 |
| transaction | AVY | 2025 MSU Award | Options Exercise | $0 | -431 | -24% | $0.000000 | 1,348 | 01 Mar 2026 | Common Stock | 431 | $0.000000 | Direct | F6 |
| transaction | AVY | 2023 PU Award | Options Exercise | $0 | -782 | -100% | $0.000000 | 0 | 01 Mar 2026 | Common Stock | 782 | $0.000000 | Direct | F7 |
| Id | Content |
|---|---|
| F1 | Restricted stock units (RSUs) vest 25% on each of the first, second, third and fourth anniversaries of the grant date. Each RSU represents a contingent right to receive one share of common stock. |
| F2 | Performance units (PUs) vest, at the end of fiscal year 2028, provided certain performance objectives are met as determined by the Compensation Committee in February 2029. Each PU represents a contingent right to receive one share of common stock. |
| F3 | Shares reflect the vesting of the fourth tranche of MSUs granted in February 2022 at 92% of target based on our absolute total stockholder return in excess of 10% during the 2022-2025 performance period, plus dividend equivalents accrued during the period. |
| F4 | Shares reflect the vesting of the third tranche of MSUs granted in March 2023 at 96% of target based on our absolute total stockholder return during the 2023-2025 performance period, plus dividend equivalents accrued during the period. |
| F5 | Shares reflect the vesting of the second tranche of MSUs granted in March 2024 at 92% of target based on our absolute total stockholder return during the 2024-2025 performance period, plus dividend equivalents accrued during the period. |
| F6 | Shares reflect the vesting of the first tranche of MSUs granted in March 2025 at 94% of target based on our absolute total stockholder return during the 2025 performance period, plus dividend equivalents accrued during the period. |
| F7 | Shares reflect the vesting of PUs granted in March 2023 at 56% of target, based 50% on our cumulative economic value added of 0% of target and 50% on our relative total stockholder return of 112% of target. |